|
Jul 19
|
Lisata to use Haystack’s MRD tests for pancreatic cancer therapy trial
|
|
Jul 18
|
Haystack Oncology, Lisata Therapeutics Collaborate on Pancreatic Cancer Therapy
|
|
Jul 18
|
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
|
|
Jul 18
|
EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy
|
|
Jul 16
|
Lisata (LSTA) Stock Rallies More Than 30% YTD: Here's Why
|
|
Jul 16
|
Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma
|